Price

rebased to 0%

AMGN, solidPRME, dashed

AMGNAmgen Inc

465.45−0.12%· post 466.36

Mkt cap$251.6BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

PRMEPrime Medicine, Inc.

4.44−6.04%· post 4.44

ClosedNov 2 '26

Mkt cap—Revenue$1MQ2 FY26Revenue$5MFY25

vs

Compare

ClosedNov 2 '26

AMGNAmgen Inc

vs

PRMEPrime Medicine, Inc.

465.45−0.12%post 466.36

Price

4.44−6.04%post 4.44

$251.6B

Mkt cap

—

Q2 FY26$10.1B

Revenue

$1MQ2 FY26

FY25$36.8B

Revenue

$5MFY25

AMGN compared with PRME: revenue, margins and what each company keeps, and the suppliers and customers both name